News
Stay up to date on the latest company news:
09 October 2024
Abalos Therapeutics Appoints Gerben Moolhuizen as Chief Executive Officer
18 March 2024
Abalos selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)
18 October 2022
Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer
12 August 2022
Abalos Therapeutics---arenaviruses take on cancer
14 October 2021
Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million
05 February 2020
Abalos Therapeutics Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts
15 October 2019
Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
Events
Want to get in touch with the Abalos Therapeutics Team? Meet us at the following events:
February 26-27, 2025
Sachs Associates 18th Annual European Life Sciences CEO Forum
Location: Zurich, Switzerland
Presentation: Oral company presentation
Presenters: Gerben Moolhuizen, CEO
Date: February 26-27, 2025
March 12-14, 2025
SITC Spring Scientific
Location: San Diego, USA
Poster Presentation: Arenavirus immunotherapy induces favorable anti-tumor immune mechanisms improving checkpoint and cell therapies
Presenter: Ulrike Köhler, Research Scientist
Date: March 12, 2025, at 5.10 – 6.45 pm PT
Poster Number: #69
April 3, 2025
Innovation for Health
April 9-10, 2025
German Biotech Days
May 12-14, 2025
22nd CIMT Annual Meeting
Location: Mainz, Germany
Poster Title: Modulation of the tumor microenvironment by recombinant arenavirus immuno-virotherapy
Presenter: Maria Hønholt Christensen, Research Scientist
Date: May 12, 2025, 3.00pm – 5.30 pm CEST
Poster Number: 60
May 12-14, 2025
Bio€quity Europe
Location: Bruges, Belgium
Presentation: Oral company presentation
Presenter: Gerben Moolhuizen, CEO